![Liang Song](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liang Song
Directeur Général chez Insight Lifetech Co., Ltd.
Postes actifs de Liang Song
Sociétés | Poste | Début | Fin |
---|---|---|---|
Insight Lifetech Co., Ltd.
![]() Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Directeur Général | 11/12/2015 | - |
Président | 21/06/2017 | - | |
Fondateur | 11/12/2015 | - |
Historique de carrière de Liang Song
Anciens postes connus de Liang Song
Sociétés | Poste | Début | Fin |
---|---|---|---|
The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 01/02/2011 | 01/03/2016 |
Formation de Liang Song
Wuhan University | Undergraduate Degree |
The Chinese University of Hong Kong | Graduate Degree |
Washington University in St. Louis | Doctorate Degree |
Statistiques
Internationale
Chine | 4 |
Hong Kong | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectorielle
Consumer Services | 5 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Insight Lifetech Co., Ltd.
![]() Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
- Bourse
- Insiders
- Liang Song
- Expérience